PLEXIFORM NEUROFIBROMA
Clinical trials for PLEXIFORM NEUROFIBROMA explained in plain language.
Never miss a new study
Get alerted when new PLEXIFORM NEUROFIBROMA trials appear
Sign up with your email to follow new studies for PLEXIFORM NEUROFIBROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to shrink debilitating nerve tumors
Disease control OngoingThis study is testing an oral drug called mirdametinib for people with neurofibromatosis type 1 (NF1) who have painful, inoperable nerve tumors called plexiform neurofibromas. The main goal is to see if the drug can shrink these tumors by at least 20% and reduce pain and other sy…
Matched conditions: PLEXIFORM NEUROFIBROMA
Phase: PHASE2 • Sponsor: SpringWorks Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Decade-Long quest to map the journey of a complex genetic disorder
Knowledge-focused OngoingThis study aims to understand how Neurofibromatosis Type 1 (NF1) changes over many years in children and adults. Researchers will follow about 260 participants for up to 10 years, performing regular check-ups, scans, and tests to track tumors, pain, and quality of life. The goal …
Matched conditions: PLEXIFORM NEUROFIBROMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC